MedTrace Logo

Botanical Blend on the Gut Microbiome and Gut-Skin-Axis in Small Intestinal Bacterial Overgrowth (SIBO)

NCT04867512 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2021-05-04

No results posted yet for this study

Summary

The purpose of this study is to assess how an oral botanical blend alters the gut microbiome and the skin biophysical properties in people with SIBO.

Conditions

  • Small Intestinal Bacterial Overgrowth (SIBO)

Interventions

DIETARY_SUPPLEMENT

Liquid Tincture

Biocidin Liquid Tincture: 1 drop by mouth twice daily, increased by one drop each day until 15 drops twice daily have been reached. 15 drops by mouth twice daily will be maintained through the duration of the study.

DIETARY_SUPPLEMENT

GI Detox

GI Detox: 2 capsules by mouth every evening and 1 hour away from all food maintained through the duration of the study.

DIETARY_SUPPLEMENT

Olivirex

Olivirex: 2 capsules by mouth twice daily taken with Biocidin liquid tincture starting at week 10 until week 14 of the study for non-responders determined by symptoms and lactulose breath test results.

Sponsors & Collaborators

  • Biocidin

    collaborator UNKNOWN

  • Integrative Skin Science and Research

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-04-27
Primary Completion
2021-04-30
Completion
2022-02-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04867512 on ClinicalTrials.gov